# EDGAR Filing Document

**Accession Number:** 0001438226
**File Stem:** 0001156039-26-000002
**Filing Date:** 2026-1
**Character Count:** 10850
**Document Hash:** 8cd4ee6593e30c7562a93b6bc68be9cd
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001156039-26-000002.hdr.sgml**: 20260114

**ACCESSION NUMBER**: 0001156039-26-000002

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260112

**FILED AS OF DATE**: 20260114

**DATE AS OF CHANGE**: 20260114

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** SCHULMAN AMY W
- **CENTRAL INDEX KEY:** 0001438226

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16751
- **FILM NUMBER:** 26533424

**MAIL ADDRESS:**
- **STREET 1:** PFIZER INC. ATTN: CORPORATE SECRETARY
- **STREET 2:** 235 EAST 42ND STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10017
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Elevance Health, Inc.
- **CENTRAL INDEX KEY:** 0001156039
- **STANDARD INDUSTRIAL CLASSIFICATION:** HOSPITAL & MEDICAL SERVICE PLANS [6324]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 352145715
- **STATE OF INCORPORATION:** IN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 220 VIRGINIA AVENUE
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46204
- **BUSINESS PHONE:** 8003311476

**MAIL ADDRESS:**
- **STREET 1:** 220 VIRGINIA AVENUE
- **CITY:** INDIANAPOLIS
- **STATE:** IN
- **ZIP:** 46204

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Anthem, Inc.
- **DATE OF NAME CHANGE:** 20141202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WELLPOINT, INC
- **DATE OF NAME CHANGE:** 20100105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WELLPOINT INC
- **DATE OF NAME CHANGE:** 20041130

## Ex-24

```

POWER OF ATTORNEY

     Know all by these presents, that the undersigned hereby
makes, constitutes and appoints each of Kathleen S. Kiefer
and Issa O. Yesufu, with full power of substitution and
re-substitution, acting individually, as the undersigned's
true and lawful attorney-in-fact (each of such persons and
their substitutes hereafter referred to as an "Attorney-in-Fact"),
with full power and authority as hereinafter described on behalf
of and in the undersigned's name, place and stead, in any and all
capacities to:

(1) obtain credentials (including codes or passwords) to enable
the undersigned to submit and file documents, forms and information
required by Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") or any rule or regulation of the
U.S. Securities and Exchange Commission (the "SEC") via the
Electronic Data Gathering and Retrieval ("EDGAR") system, including
(i) preparing, executing in the undersigned's name and on the
undersigned's behalf, and submitting to the SEC a Form ID (and any
amendments thereto) or any other documents necessary or appropriate
to obtain such credentials and legally bind the undersigned for
purpose of the Form ID or such other documents; and (ii) enrolling
the undersigned in EDGAR Next or any successor filing system;

(2) act as an account administrator for the undersigned's EDGAR
account, including: (i) appointing, removing and replacing account
administrators, technical administrators, account users, and
delegated entities; (ii) maintaining the security of the undersigned's
EDGAR account, including modification of access codes; (iii)
maintaining, modifying and certifying the accuracy of information
on the undersigned's EDGAR account dashboard; and (iv) taking any
other actions contemplated by Rule 10 of Regulation S-T;

(3) cause Elevance Health, Inc., (the "Company") to accept a
delegation of authority from the undersigned's EDGAR account
administrators and authorize such delegate's EDGAR account
administrators pursuant to that delegated entity designation to
appoint, remove or replace users for the undersigned's EDGAR account;

(4) prepare, execute and submit to the SEC, the Company, and any
national securities exchange on which the Company's securities are
listed, for and on behalf of the undersigned and in the undersigned's
capacity as an officer and/or director of the Company, any and all
reports (including any amendments thereto) that are required to be
filed with such body, or which any Attorney-in-Fact considers
advisable to file with such body, including but not limited to
Forms 3, 4 and 5 relating to the Company in accordance with
Section 16(a) of the Exchange Act the rules and regulations
promulgated thereunder, and Forms 144 in accordance with Rule 144
under the Securities Act of 1933, as amended (the "Securities Act");

(5) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's
securities from any third party, including brokers, employee benefit
plan administrators and trustees, and the undersigned hereby
authorizes any such third parties to release any such information
to any Attorney-in-Fact and further approves and ratifies any such
release of information;

(6) do and perform any and all acts for and on behalf of the
undersigned that may be necessary or desirable to prepare, complete
and execute any such Form 3, 4 or 5, or Forms 144, and any
amendments thereto, or other required report, and timely file such
forms or reports with the SEC and any stock exchange or similar
authority as considered necessary or advisable under Section 16(a)
of the Exchange Act or Rule 144 of the Securities Act; and

(7) take any other action of any type whatsoever in connection
with the foregoing that such Attorney-in-Fact reasonably believes
may be of benefit to, in the best interest of, or legally required
of, the undersigned, it being understood that the documents
executed by such Attorney-in-Fact on behalf of the undersigned
pursuant to this Power of Attorney will be in such form and will
contain such disclosure, information, terms and conditions as
such Attorney-in-Fact, in such Attorney-in-Fact's sole discretion,
deems necessary or advisable.

     The undersigned hereby acknowledges that (a) the foregoing
Attorneys-in-Fact are serving in such capacity at the request of
the undersigned; (b) this Power of Attorney authorizes, but does
not require, each such Attorney-in-Fact to act in the
Attorney-in-Fact's discretion on information provided to such
Attorney-in-Fact without independent verification of such
information; (c) neither the Company nor any Attorney-in-Fact
assumes (i) any liability for the undersigned's responsibility
to timely comply with the requirements of the Exchange Act or the
Securities Act, (ii) any liability of the undersigned for any
failure to comply with such requirements, (iii) any liability for
any action or inaction by an Attorney-in-Fact relating to their
service as an account administrator for the undersigned's EDGAR
account, or (iv) any obligation or liability of the undersigned
for profit disgorgement under Section 16(b) of the Exchange Act;
and (d) this Power of Attorney does not relieve the undersigned
from responsibility for compliance with the undersigned's
obligations under the Exchange Act and the Securities Act,
including, without limitation, the reporting requirements under
Section 16 of the Exchange Act.

     This Power of Attorney will remain in full force and effect until
the undersigned is no longer required to file with the SEC reports or
notices with respect to the undersigned's holdings of, and transactions
in, securities issued by the Company, unless earlier revoked as to
any Attorney-in-Fact by the undersigned in a signed writing delivered
to such Attorney-in-Fact. Notwithstanding the foregoing, if any such
Attorney-in-Fact hereafter ceases to be an employee of the Company,
then this Power of Attorney will be automatically revoked solely as
to such individual, immediately upon such cessation, without any
further action by the undersigned.

IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 15th day of
December, 2025.

                                      /s/Amy W. Schulman
					 Amy W. Schulman

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>SCHULMAN AMY W<br><sub>(Last) (First) (Middle)</sub><br>220 VIRGINIA AVENUE<br><sub>(Street)</sub><br>INDIANAPOLIS, IN 46204<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Elevance Health, Inc. [ ELV ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2026-01-12 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit List: Exhibit 24 - Power of Attorney

**Signature:** /s/ Kathleen S. Kiefer, Attorney in fact  
**Date:** 2026-01-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**